FIELD: medicine, pharmaceutics.
SUBSTANCE: there are presented nitrogen-containing heterocyclic compounds presented by the following formula 
wherein the radical values are specified in the description. These compounds or their pharmaceutically acceptable salts possess strong EP1 activity if introduced in a human or an animal; they are used as an effective component of a pharmaceutical agent, e.g. for preventing and/or treating overactive bladder.
EFFECT: compounds are used as an effective component of the pharmaceutical agent for preventing and/or treating the symptoms including frequent urination, heavy urination demand accompanied by fear of involuntary urination, and urinary incontinence.
24 cl, 145 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF | 2009 |
|
RU2479579C2 |
| SPHINGOSINE-1-PHOSPHATE BINDING INHIBITOR | 2007 |
|
RU2395499C2 |
| METHOD FOR SYNTHESIS OF HYDRAZINE, WHICH CAN BE USED IN TREATMENT OF PAPILLOMA VIRUS | 2013 |
|
RU2649006C2 |
| TETRAZOLYL HYDROXYIMINE DERIVATIVE, METHOD FOR PURIFICATION THEREOF AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2581828C2 |
| DRUG AND METHOD OF TREATMENT OF PATIENTS WITH ELEVATED INTRAOCULAR PRESSURE AND/OR GLAUCOMA | 1995 |
|
RU2123847C1 |
| THERAPEUTIC DRUG OR PREVENTIVE THERAPEUTIC AGENT FOR DIABETIC NEPHROPATHY | 2017 |
|
RU2735538C1 |
| CYCLOALKYL DERIVATIVES, METHOD OF PREPARATION THEREOF, AND INTERMEDIATES | 1997 |
|
RU2197458C2 |
| CYCLIC AMINODERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT AND PROPHYLAXIS OF DISEASES | 1997 |
|
RU2163596C2 |
| COMPOSITION CONTAINING TETRACYCLIC COMPOUNDS | 2011 |
|
RU2573392C2 |
| SULFONAMIDE COMPOUND | 2006 |
|
RU2376300C1 |
